In a groundbreaking development, an open science competition called the Critical Assessment of Computational Hit-Finding Experiments (CACHE) has successfully employed artificial intelligence (AI) to discover molecules that could lead to new treatments for Parkinson’s disease. This collaborative effort involved scientists from various institutions, including Merck KGaA and the University of Pittsburgh, who identified seven commercially-available
